News
A village of two billion mums is just waiting to help you out. While we once had ancient scrolls and old wives’ tales passed ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option for treating Type I allergic reactions, including anaphylaxis ...
Neffy ® (epinephrine nasal spray) 1 mg is now available for the emergency treatment of type 1 allergic reactions, including anaphylaxis, in pediatric patients aged 4 years and older weighing 15 to ...
Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.
3d
Pharmaceutical Technology on MSNARS Pharma’s epinephrine nasal spray 1mg now available in USARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option ...
DEAR DR ROACH: I have a cold. I use two brands of nasal spray for congestion, but both say not to use them for more than three days as they may cause “rebound” congestion. Can I alternate them ...
Over time, using a nasal aspirator will be second nature, but hopefully something you won’t have to use very often. Look for nasal aspirators with multiple nose tip inserts. Having a correct fit ...
The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.
4d
Stockhead on MSNBreak it Down: LTR Pharma develops new nasal spray for OMD’sLTR Pharma has joined forces with Strategic Drug Solutions to developed a nasal spray to treat oesophageal motility disorders ...
Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results